Booth, L., Roberts, J. L., Poklepovic, A., Avogadri-Connors, F., Cutler, R. E., Lalani, A. S., & Dent, P. (2019). Correction: HDAC inhibitors enhance neratinib activity and when combined enhance the actions of an anti-PD-1 immunomodulatory antibody in vivo. Oncotarget.
Chicago Stili AlıntıBooth, Laurence, Jane L. Roberts, Andrew Poklepovic, Francesca Avogadri-Connors, Richard E. Cutler, Alshad S. Lalani, ve Paul Dent. "Correction: HDAC Inhibitors Enhance Neratinib Activity and When Combined Enhance the Actions of an Anti-PD-1 Immunomodulatory Antibody in Vivo." Oncotarget 2019.
MLA AlıntıBooth, Laurence, et al. "Correction: HDAC Inhibitors Enhance Neratinib Activity and When Combined Enhance the Actions of an Anti-PD-1 Immunomodulatory Antibody in Vivo." Oncotarget 2019.